Vision Capital Management, Inc. Amgen Inc Transaction History

Vision Capital Management, Inc.

$660 Million
Q2 2024

A detailed history of Vision Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Vision Capital Management, Inc. holds 35,160 shares of AMGN stock, worth $11.3 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares

35,160

Previous 35,917 2.11%

Holding current value

$11.3 Million

Previous $10.2 Million 7.58%

% of portfolio

1.66%

Previous 1.55%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $198,901 - $241,717	-757 Reduced 2.11%	35,160 $11 Million
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $163,741 - $197,657	-609 Reduced 1.67%	35,917 $10.2 Million
Q4 2023 Jan 17, 2024	BUY	$255.7 - $288.46 $21,990 - $24,807	86 Added 0.24%	36,526 $10.5 Million
Q3 2023 Oct 25, 2023	SELL	$218.65 - $271.46 $176,669 - $219,339	-808 Reduced 2.17%	36,440 $9.79 Million
Q2 2023 Aug 01, 2023	SELL	$214.27 - $253.37 $6,856 - $8,107	-32 Reduced 0.09%	37,248 $8.27 Million
Q1 2023 May 03, 2023	SELL	$225.79 - $275.2 $263,948 - $321,708	-1,169 Reduced 3.04%	37,280 $9.01 Million
Q4 2022 Jan 26, 2023	BUY	$229.03 - $291.01 $81,305 - $103,308	355 Added 0.93%	38,449 $0
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $711,509 - $791,786	-3,084 Reduced 7.49%	38,094 $9.27 Million
Q1 2022 Apr 28, 2022	BUY	$219.27 - $242.57 $363,330 - $401,938	1,657 Added 4.19%	41,178 $9.96 Million
Q4 2021 Jan 24, 2022	BUY	$198.88 - $227.6 $1.36 Million - $1.56 Million	6,845 Added 20.95%	39,521 $8.89 Million
Q3 2021 Oct 07, 2021	BUY	$212.27 - $248.7 $35,873 - $42,030	169 Added 0.52%	32,676 $6.95 Million
Q2 2021 Jul 15, 2021	BUY	$233.58 - $259.14 $94,599 - $104,951	405 Added 1.26%	32,507 $7.92 Million
Q1 2021 Apr 21, 2021	SELL	$221.91 - $258.6 $38,612 - $44,996	-174 Reduced 0.54%	32,102 $7.99 Million
Q4 2020 Jan 20, 2021	BUY	$216.38 - $257.67 $463,485 - $551,929	2,142 Added 7.11%	32,276 $7.42 Million
Q3 2020 Oct 21, 2020	SELL	$234.65 - $260.95 $13,140 - $14,613	-56 Reduced 0.19%	30,134 $7.66 Million
Q2 2020 Jul 24, 2020	BUY	$197.81 - $242.74 $251,812 - $309,008	1,273 Added 4.4%	30,190 $7.12 Million
Q1 2020 Apr 14, 2020	BUY	$182.24 - $241.7 $820,808 - $1.09 Million	4,504 Added 18.45%	28,917 $5.86 Million
Q4 2019 Jan 21, 2020	SELL	$189.21 - $243.2 $23,840 - $30,643	-126 Reduced 0.51%	24,413 $5.89 Million
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $103,943 - $124,546	597 Added 2.49%	24,539 $4.75 Million
Q2 2019 Jul 29, 2019	BUY	$166.7 - $195.41 $2.67 Million - $3.13 Million	16,013 Added 201.95%	23,942 $4.41 Million
Q1 2019 May 01, 2019	BUY	$180.87 - $203.88 $1.43 Million - $1.62 Million	7,929 New	7,929 $1.51 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vision Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vision Capital Management, Inc. with notifications on news.

Account

Vision Capital Management, Inc. Amgen Inc Transaction History